Cargando…

NEK2 plays an active role in Tumorigenesis and Tumor Microenvironment in Non-Small Cell Lung Cancer

Abnormal expression and dysfunction of Never-in-mitosis-A-related kinase 2 (NEK2) result in tumorigenesis. High levels of NEK2 are related to malignant progression, drug resistance, and poor prognosis. However, the relationship between NEK2 levels and the occurrence of non-small cell lung cancer (NS...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bai, Rui, Yuan, Cheng, Sun, Wenjie, Zhang, Jianguo, Luo, Yuan, Gao, Yanping, Li, Yangyi, Gong, Yan, Xie, Conghua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2021
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8193268/ https://www.ncbi.nlm.nih.gov/pubmed/34131401 http://dx.doi.org/10.7150/ijbs.59019

Ejemplares similares

NEK2 plays an active role in Tumorigenesis and Tumor Microenvironment in Non-Small Cell Lung Cancer: Retraction
por: Bai, Rui, et al.
Publicado: (2022)

Establishment of the Prognostic Index Reflecting Tumor Immune Microenvironment of Lung Adenocarcinoma Based on Metabolism-Related Genes
por: Zhang, Jianguo, et al.
Publicado: (2020)

Effects of MicroRNA-195-5p on Biological Behaviors and Radiosensitivity of Lung Adenocarcinoma Cells via Targeting HOXA10
por: Yuan, Cheng, et al.
Publicado: (2021)

Differential effects of WRAP53 transcript variants on non-small cell lung cancer cell behaviors
por: Zhu, Yan, et al.
Publicado: (2023)

Establishment of Immune-related Gene Pair Signature to Predict Lung Adenocarcinoma Prognosis
por: Jiang, Xueping, et al.
Publicado: (2020)

Establishment of the prognostic index of lung squamous cell carcinoma based on immunogenomic landscape analysis
por: Zhang, Jianguo, et al.
Publicado: (2020)

GPR87 promotes tumor cell invasion and mediates the immunogenomic landscape of lung adenocarcinoma
por: Bai, Rui, et al.
Publicado: (2022)

HHLA2 deficiency inhibits non‐small cell lung cancer progression and THP‐1 macrophage M2 polarization
por: Sun, Wenjie, et al.
Publicado: (2021)

LncRNA PCAT1 activates SOX2 and suppresses radioimmune responses via regulating cGAS/STING signalling in non‐small cell lung cancer
por: Gao, Yanping, et al.
Publicado: (2022)

Immune and stromal scoring system associated with tumor microenvironment and prognosis: a gene-based multi-cancer analysis
por: Zeng, Zihang, et al.
Publicado: (2021)

SETD2 mediates immunotherapy and radiotherapy efficacy via regulating DNA damage responses and genomic stability in lung adenocarcinoma
por: Zeng, Zihang, et al.
Publicado: (2022)

Stromal microenvironment promoted infiltration in esophageal adenocarcinoma and squamous cell carcinoma: a multi-cohort gene-based analysis
por: Li, Jiali, et al.
Publicado: (2020)

SAMHD1 silencing cooperates with radiotherapy to enhance anti-tumor immunity through IFI16-STING pathway in lung adenocarcinoma
por: Li, Yangyi, et al.
Publicado: (2022)

Biomineralized Manganese Oxide Nanoparticles Synergistically Relieve Tumor Hypoxia and Activate Immune Response with Radiotherapy in Non-Small Cell Lung Cancer
por: Liu, Xinyu, et al.
Publicado: (2022)

SETD2 regulates gene transcription patterns and is associated with radiosensitivity in lung adenocarcinoma
por: Zeng, Zihang, et al.
Publicado: (2022)

Agrin Promotes Non-Small Cell Lung Cancer Progression and Stimulates Regulatory T Cells via Increasing IL-6 Secretion Through PI3K/AKT Pathway
por: Han, Linzhi, et al.
Publicado: (2022)

Role of tumor microenvironment in tumorigenesis
por: Wang, Maonan, et al.
Publicado: (2017)

RRM2 silencing suppresses malignant phenotype and enhances radiosensitivity via activating cGAS/STING signaling pathway in lung adenocarcinoma
por: Jiang, Xueping, et al.
Publicado: (2021)

Correction: RRM2 silencing suppresses malignant phenotype and enhances radiosensitivity via activating cGAS/STING signaling pathway in lung adenocarcinoma
por: Jiang, Xueping, et al.
Publicado: (2022)

Kinase Inhibitor Profile for Human Nek1, Nek6, and Nek7 and Analysis of the Structural Basis for Inhibitor Specificity
por: Moraes, Eduardo Cruz, et al.
Publicado: (2015)

Aberrant expression of NEK2 and its clinical significance in non-small cell lung cancer
por: ZHONG, XINWEN, et al.
Publicado: (2014)

Analysis of the effect of NEKs on the prognosis of patients with non-small-cell lung carcinoma based on bioinformatics
por: Yang, Mengxia, et al.
Publicado: (2022)

Inhibition of Nek2 by Small Molecules Affects Proteasome Activity
por: Meng, Lingyao, et al.
Publicado: (2014)

Physiological and Pathological Roles of Mammalian NEK7
por: Sun, Zhenzhen, et al.
Publicado: (2020)

The prognostic value of tumor mutational burden and immune cell infiltration in esophageal cancer patients with or without radiotherapy
por: Yuan, Cheng, et al.
Publicado: (2020)

Mechanistic basis of Nek7 activation through Nek9 binding and induced dimerization
por: Haq, Tamanna, et al.
Publicado: (2015)

Molecular modeling and docking of small molecule inhibitors against NEK2
por: Ramachandran, Balaji, et al.
Publicado: (2016)

NEK2 serves as a prognostic biomarker for hepatocellular carcinoma
por: Li, Gang, et al.
Publicado: (2017)

Multistep tumorigenesis and the microenvironment
por: Schedin, Pepper, et al.
Publicado: (2004)

ATG7 promotes the tumorigenesis of lung cancer but might be dispensable for prognosis predication: a clinicopathologic study
por: Sun, Shaoxing, et al.
Publicado: (2016)

Gene signature based on B cell predicts clinical outcome of radiotherapy and immunotherapy for patients with lung adenocarcinoma
por: Han, Linzhi, et al.
Publicado: (2020)

NEK4 kinase regulates EMT to promote lung cancer metastasis
por: Ding, Nian‐Hua, et al.
Publicado: (2018)

The Tumor Microenvironment in Tumorigenesis and Therapy Resistance Revisited
por: Dzobo, Kevin, et al.
Publicado: (2023)

Small Nucleolar RNA 71A Promotes Lung Cancer Cell Proliferation, Migration and Invasion via MAPK/ERK Pathway
por: Tang, Guiliang, et al.
Publicado: (2019)

Downregulated ADAMTS1 Incorporating A2M Contributes to Tumorigenesis and Alters Tumor Immune Microenvironment in Lung Adenocarcinoma
por: Lee, Hsiao-Chen, et al.
Publicado: (2022)

Mitotic Regulation by NEK Kinase Networks
por: Fry, Andrew M., et al.
Publicado: (2017)

Up to your NEK2 in CIN
por: Seachrist, Darcie D., et al.
Publicado: (2021)

Trichosanthin enhances sensitivity of non-small cell lung cancer (NSCLC) TRAIL-resistance cells
por: You, Chengcheng, et al.
Publicado: (2018)

An Autoinhibitory Tyrosine Motif in the Cell-Cycle-Regulated Nek7 Kinase Is Released through Binding of Nek9
por: Richards, Mark W., et al.
Publicado: (2009)

Characterization of the Human NEK7 Interactome Suggests Catalytic and Regulatory Properties Distinct from Those of NEK6
por: de Souza, Edmarcia Elisa, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_01ki3o8e9h6res7pfp2h9g99b1